Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis--a study of bile cultures from ERCP.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Hepato-Gastroenterology

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 11148988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary sclerosing cholangitis

  2001cited by this paper
• Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features.

  1999cited by this paper
• Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.

  1998cited by this paper
• Piperacillin To Prevent Cholangitis after Endoscopic Retrograde Cholangiopancreatography

  1996cited by this paper
• Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

  1996cited by this paper
• Prognostic value of cholangiography in primary sclerosing cholangitis.

  1995cited by this paper
• HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.

  1995cited by this paper
• Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study.

  1995cited by this paper
• Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium.

  1994cited by this paper
• Bacteremia following diagnostic and therapeutic ERCP.

  1992cited by this paper
• Relationship of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

  1991cited by this paper
• Antibiotic Prophylaxis of Infectious Complications with Endoscopic Retrograde Cholangiopancreatography. A Randomized Controlled Study

  1990cited by this paper
• Septic complications following endoscopic retrograde cholangiopancreatography: the experience in Tel Aviv Medical Center.

  1988cited by this paper
• Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis.

  1988cited by this paper
• Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits.

  1988cited by this paper
• Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease.

  1988cited by this paper
• Enhanced autoreactivity of T‐lymphocytes in primary sclerosing cholangitis

  1987cited by this paper
• Familial occurrence of primary sclerosing cholangitis and ulcerative colitis.

  1983cited by this paper
• Association of primary sclerosing cholangitis with HLA-B8.

  1983cited by this paper
• Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts.

  1982cited by this paper
• ERCP: Complications and prophylaxis a controlled study.

  1981cited by this paper
• Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery.

  1980cited by this paper
• The bacterial flora of the biliary tract and liver in man

  1978cited by this paper
• Anaerobic and aerobic bacteriological studies in biliary tract disease.

  1976cited by this paper
• Bacteriology of the gallbladder bile in normal subjects.

  1975cited by this paper
• Primary sclerosing cholangitis. A study of forty-two cases.

  1966cited by this paper
• Experimental Chronic Portal Vein Bacteremia.∗

  1964cited by this paper
• THE IMPORTANCE OF THE ROUTE OF INFECTION IN EXPERIMENTAL BILIARY TRACT OBSTRUCTION.

  1964cited by this paper
• The liver in ulcerative colitis; the significance of raised serum-alkaline-phosphatase levels.

  1959cited by this paper

• SPANISH CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF CHOLESTATIC LIVER DISEASES IN ADULT AND PEDIATRIC POPULATION: JOINT REPORT FROM AEEH AND SEGHNP.

  2025cites this paper
• Microbial Landscapes of the Gut–Biliary Axis: Implications for Benign and Malignant Biliary Tract Diseases

  2025cites this paper
• EASL Clinical Practice Guidelines on Sclerosing Cholangitis.

  2022cites this paper
• Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases

  2022cites this paper
• The microbiota and the gut–liver axis in primary sclerosing cholangitis

  2022cites this paper
• Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients

  2021cites this paper
• Recent advances in the treatment of primary sclerosing cholangitis

  2020cites this paper
• Biliary tract microbiota: a new kid on the block of liver diseases?

  2020cites this paper
• Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.

  2019cites this paper
• Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.

  2019cites this paper
• Primary sclerosing cholangitis: best practices for diagnosis

  2017cites this paper
• Emerging pharmacologic therapies for primary sclerosing cholangitis

  2017cites this paper
• The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts

  2017cites this paper
• Role of the Intestinal Microbiome in Cholestatic Liver Disease

  2017cites this paper
• Primary sclerosing cholangitis: best practices for diagnosis

  2017cites this paper
• A review of the medical treatment of primary sclerosing cholangitis in the 21st century

  2016cites this paper
• Primary sclerosing cholangitis: 50 years of a gut–liver relationship and still no love?

  2016cites this paper
• Extraintestinal Manifestations Associated with Inflammatory Bowel Disease.

  2015cites this paper
• PRIMARNI SKLEROZIRAJUĆI KOLANGITIS

  2015cites this paper
• The regulation of inflammatory liver responses by the TNF ligand and receptor system-TWEAK and Fn14, via human intra-hepatic endothelial cells

  2015cites this paper
• Primary sclerosing cholangitis – the Norwegian experience

  2015cites this paper
• Endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis.

  2014cites this paper
• Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation

  2013cites this paper
• Mucosal immunity in liver autoimmunity: a comprehensive review.

  2013cites this paper
• Nachweis pathogener Keime in Lebergewebe und Galle bei Patienten während Lebertransplantation

  2013cites this paper
• Extraintestinal Manifestations of Inflammatory Bowel Disease: Primary Sclerosing Cholangitis

  2012cites this paper
• Nachweis pathogener Keime in Lebergewebe und Galle bei Patienten während Lebertransplantation

  2012cites this paper
• Hepatobiliary disorders and complications of inflammatory bowel disease

  2011cites this paper
• Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn’s disease: correlation of transient elastography and laboratory-based markers

  2011cites this paper
• Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

  2011cites this paper
• Medical and endoscopic therapy of primary sclerosing cholangitis.

  2011cites this paper
• Aetiopathology and management of secondary sclerosing cholangitis following burn injury

  2011cites this paper
• Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease

  2010cites this paper
• Diagnosis and management of primary sclerosing cholangitis

  2010cites this paper
• Gallbladder and pancreatic disease in patients with primary sclerosing cholangitis

  2010cites this paper
• Treatment options for primary sclerosing cholangitis

  2010cites this paper
• Atypical p-ANCA in PSC and AIH: A Hint Toward a “leaky gut”?

  2009cites this paper
• Primary Sclerosing Cholangitis: A Clinical Case

  2009cites this paper
• Best Practice & Research Clinical Gastroenterology

  2009cites this paper
• Bile Infection and Bile Acids Concentration in Bile in Acute Biliary Pancreatitis

  2009cites this paper
• Long-term Treatment of Primary Sclerosing Cholangitis in Children With Oral Vancomycin: An Immunomodulating Antibiotic

  2008cites this paper
• Clinical features and management of primary sclerosing cholangitis.

  2008cites this paper
• Gallbladder disease in patients with primary sclerosing cholangitis.

  2008cites this paper
• Etiopathogenesis of primary sclerosing cholangitis.

  2008cites this paper
• Primary sclerosing cholangitis.

  2008cites this paper
• Sero-bacteriological detection of bacteria in the gall bladder, blood and stool of patients having cholecystectomy

  2008cites this paper
• The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.

  2008cites this paper
• Manifestaciones hepatobiliares en la enfermedad inflamatoria intestinal

  2007cites this paper
• [Hepatobiliary manifestations in inflammatory bowel disease].

  2007cites this paper
• Bacterial Infection-Related Morbidity and Mortality in Cirrhosis

  2007cites this paper
• Bactobilia after liver transplantation: Frequency and antibiotic susceptibility

  2006cites this paper
• Etiopathogenesis of Primary Sclerosing Cholangitis

  2006cites this paper
• Biliary candida infections in primary sclerosing cholangitis.

  2006cites this paper
• The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis

  2006cites this paper
• Etiopathogenesis of primary sclerosing cholangitis.

  2006cites this paper
• Biliary candida infections in primary sclerosing cholangitis

  2006cites this paper
• The immunobiology of primary sclerosing cholangitis.

  2005cites this paper
• Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis

  2005influential citation
• Immunopathogenesis of primary sclerosing cholangitis

  2005cites this paper
• 189-196 Evaluation of

  2004cites this paper
• Dominant Strictures in Patients with Primary Sclerosing Cholangitis

  2004cites this paper
• Endoscopic Therapy in Primary Sclerosing Cholangitis. Dominant Strictures May Not Matter: Does that Mean that Endotherapy Does Not Work?

  2004cites this paper
• Hepatic metabisulfite sensitivity in a patient with sclerosing cholangitis.

  2003cites this paper
• Do pancreatic duct stents cause or prevent pancreatic sepsis?

  2003cites this paper
• Sclerosing cholangitis.

  2002cites this paper
• Lipid metabolism and therapy

  2002cites this paper
• The role of cholangiocytes in the development of chronic inflammatory liver disease.

  2002cites this paper
• Identification of Helicobacter pylori and OtherHelicobacter Species by PCR, Hybridization, and Partial DNA Sequencing in Human Liver Samples from Patients with Primary Sclerosing Cholangitis or Primary Biliary Cirrhosis

  2000cites this paper